4.8

CVE-2026-94016: sourcecodester drug recommendation system Cross-site Scripting

CVSS: 4.8v4.0MediumDeferred
Published 20-09-2026Last modified 28-09-2026

Vulnerability summary

CVE-2026-94016 is a medium (CVSS 4.8) Cross-site Scripting vulnerability in sourcecodester drug recommendation system. EPSS estimates a 0.37% chance of exploitation in the next 30 days, higher than 29.2% of scored vulnerabilities. 1 public exploit is recorded.

Overall risk
29/100
0100
Medium · default modelHow is this calculated?
CVSS score
4.8/10
010
Medium · v4.0 (CVE.org)
EPSS score
0.37%
0%100%
Low · Change unavailable
KEVNot listedIn no KEV catalog
RansomwareNone recordedNo known use recorded
Public exploits1github

Timeline

  1. 20-09-2026
    PublishedVulnerability first disclosed.
  2. 28-09-2026
    Last modifiedVulnerability information updated.

Description

A security flaw has been discovered in SourceCodester Drug Recommendation System 1.0. This impacts an unknown function of the file /drug_recommender/Admin/add_symptom. Performing a manipulation of the argument txtname results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be used for attacks.

CVSS metrics

7 scores · 2 sources · 4 versions

EPSS trend

Probability

0.37%

Chance of exploitation in the next 30 days

Percentile

29%

Versus all other CVEs

30-day change

Change unavailable

Change unavailable

21-09-202620-10-2026
EPSS score
0.37%

Known exploited

Compare KEV catalogs

Not in any of the 3 tracked catalogs.

Public exploits

1 found
  • githubUnverified

    Drug Recommendation System

    Maturity: poc

Weaknesses

CWE · root cause

Affected systems

Sourcecodester1 product

1 vendor · 1 product

References

6 links